Literature DB >> 11469400

Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes.

M A Statnick1, L S Beavers, L J Conner, H Corominola, D Johnson, C D Hammond, R Rafaeloff-Phail, T Seng, T M Suter, J P Sluka, E Ravussin, R A Gadski, J F Caro.   

Abstract

We have screened a subtracted cDNA library in order to identify differentially expressed genes in omental adipose tissue of human patients with Type 2 diabetes. One clone (#1738) showed a marked reduction in omental adipose tissue from patients with Type 2 diabetes. Sequencing and BLAST analysis revealed clone #1738 was the adipocyte-specific secreted protein gene apM1 (synonyms ACRP30, AdipoQ, GBP28). Consistent with the murine orthologue, apM1 mRNA was expressed in cultured human adipocytes and not in preadipocytes. Using RT-PCR we confirmed that apM1 mRNA levels were significantly reduced in omental adipose tissue of obese patients with Type 2 diabetes compared with lean and obese normoglycemic subjects. Although less pronounced, apM1 mRNA levels were reduced in subcutaneous adipose tissue of Type 2 diabetic patients. Whereas the biological function of apM1 is presently unknown, the tissue specific expression, structural similarities to TNFalpha, and the dysregulated expression observed in obese Type 2 diabetic patients suggest that this factor may play a role in the pathogenesis of insulin resistance and Type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11469400      PMCID: PMC2477762          DOI: 10.1155/edr.2000.81

Source DB:  PubMed          Journal:  Int J Exp Diabetes Res        ISSN: 1560-4284


  34 in total

1.  CCR2 modulates inflammatory and metabolic effects of high-fat feeding.

Authors:  Stuart P Weisberg; Deborah Hunter; Reid Huber; Jacob Lemieux; Sarah Slaymaker; Kris Vaddi; Israel Charo; Rudolph L Leibel; Anthony W Ferrante
Journal:  J Clin Invest       Date:  2005-12-08       Impact factor: 14.808

Review 2.  Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.

Authors:  Sanja Stojsavljević; Marija Gomerčić Palčić; Lucija Virović Jukić; Lea Smirčić Duvnjak; Marko Duvnjak
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

3.  Increased abundance of the adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif (APPL1) in patients with obesity and type 2 diabetes: evidence for altered adiponectin signalling.

Authors:  R M Holmes; Z Yi; E De Filippis; R Berria; S Shahani; P Sathyanarayana; V Sherman; K Fujiwara; C Meyer; C Christ-Roberts; H Hwang; J Finlayson; L Q Dong; L J Mandarino; M Bajaj
Journal:  Diabetologia       Date:  2011-05-12       Impact factor: 10.122

Review 4.  Systemic and brain metabolic dysfunction as a new paradigm for approaching Alzheimer's dementia.

Authors:  Vincenzo Giordano; Gianfranco Peluso; Maurizio Iannuccelli; Paola Benatti; Raffaella Nicolai; Menotti Calvani
Journal:  Neurochem Res       Date:  2006-08-17       Impact factor: 3.996

5.  Polymorphism of adiponectin (45T/G) and adiponectin receptor-2 (795G/A) in an Iranian population: relation with insulin resistance and response to treatment with pioglitazone in patients with type 2 diabetes mellitus.

Authors:  Fatemeh Namvaran; Parvaneh Rahimi-Moghaddam; Negar Azarpira; Mohammad Hosein Dabbaghmanesh
Journal:  Mol Biol Rep       Date:  2011-12-21       Impact factor: 2.316

Review 6.  The endocrine system in diabetes mellitus.

Authors:  Hisham Alrefai; Hisham Allababidi; Shiri Levy; Joseph Levy
Journal:  Endocrine       Date:  2002-07       Impact factor: 3.633

7.  Adiponectin secretion and response to pioglitazone is depot dependent in cultured human adipose tissue.

Authors:  Susan A Phillips; Theodore P Ciaraldi; Deborah K Oh; Michelle K Savu; Robert R Henry
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-07-29       Impact factor: 4.310

8.  Impact of type 1 diabetes and insulin treatment on plasma levels and fractional synthesis rate of retinol-binding protein 4.

Authors:  Marion Jourdan; Abdul Jaleel; Helen Karakelides; G Charles Ford; Barbara B Kahn; K Sreekumaran Nair
Journal:  J Clin Endocrinol Metab       Date:  2009-10-22       Impact factor: 5.958

9.  Adiponectin and adiponectin receptor gene variants in relation to type 2 diabetes and insulin resistance-related phenotypes.

Authors:  Viktor A Potapov; Dimitry A Chistiakov; Anna Dubinina; Minara S Shamkhalova; Marina V Shestakova; Valery V Nosikov
Journal:  Rev Diabet Stud       Date:  2008-05-10

10.  Plasma adiponectin and insulin resistance in Korean type 2 diabetes mellitus.

Authors:  Mi-Jin Kim; Kwang-Ha Yoo; Hyung-Suk Park; Sang-Man Chung; Choon-Jo Jin; Yoen Lee; Young-Goo Shin; Choon-Hee Chung
Journal:  Yonsei Med J       Date:  2005-02-28       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.